Physician profile
Scott Haig
NPI 1114941499
$2,294.99
in general payments reported to CMS, 2019-2025
13 companies · $80.88 in 2025
The $80.88 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,228 · 2020: $141 · 2021: $91.39 · 2022: $267 · 2023: $261 · 2024: $225 · 2025: $80.88.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $566.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $566.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $1,417.61 | 2019-2025 | Bone Anchors With Arthroscopic Delivery System, Healicoil, Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Depuy Synthes Sales INC. | $235.95 | 2019-2025 | Monovisc |
| Stryker Corporation | $222.11 | 2019-2023 | Variax, Axsos |
| Zimmer Biomet Holdings, INC. | $129.04 | 2022 | |
| Pacira Therapeutics, INC. | $47.74 | 2019-2020 | |
| Novo Nordisk INC | $40.14 | 2023-2024 | Wegovy, Saxenda |
| Treace Medical Concepts, INC. | $37.85 | 2023 | |
| Endo Pharmaceuticals INC. | $35.70 | 2019-2023 | Xiaflex |
| Kowa Pharmaceuticals America, INC. | $30.29 | 2023 | Seglentis |
| Orthofix Medical, INC. | $28.03 | 2021 | |
| Nalu Medical, INC. | $27.13 | 2025 | Nalu Neurostimulation System |
| Fidia Pharma USA INC. | $22.66 | 2024 | Hymovis |
| Horizon Therapeutics Plc | $20.74 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Haig listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.